| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |